Rare diseases
Investigational molecules
Locations
Back to Greece4 clinical trials in Kalamaria, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
GreeceLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
GreeceGreeceA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on atherosclerotic cardiovascular disease in patients with end-stage kidney disease are being conducted. The research aims to evaluate novel therapeutic approaches for patients undergoing dialysis treatment.
These studies specifically examine the effectiveness of targeted treatments in reducing C-reactive protein levels, a key marker of inflammation in cardiovascular disease among dialysis patients.
Current research explores the intersection of kidney disease and cardiovascular complications, with a particular focus on patients receiving maintenance dialysis treatment.
The trials investigate intravenous therapeutic options designed to improve outcomes for patients with complex cardiovascular and renal conditions.
Specialized studies are evaluating the role of inflammation markers in cardiovascular complications among dialysis patients, testing innovative therapeutic approaches.
This research aims to advance our understanding of inflammation's role in cardiovascular disease among patients with kidney failure.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
